PL EN


Preferences help
enabled [disable] Abstract
Number of results
2015 | 11 | 1-17
Article title

Development and validation of dissolution method for levocetirizine dihydrochloride by isocratic reverse phase HPLC

Content
Title variants
Languages of publication
EN
Abstracts
EN
Levocetirizine hydrochloride is an orally active, non-sedative antihistamine used in the symptomatic relief of seasonal and perennial allergic rhinitis. The main objective of the proposed study is to develop and validate a dissolution method of Levocetirizine hydrochloride dosage form by reverse phase HPLC isocratic method. The method is optimized by various filteration methods such as centrifuge and whatman 42. The filteration methods are evaluated by reverse phase isocratic HPLC method using column- Phenomenex Luna - C 18 (250 mm x 4.6 mm; 5 µ), mobile phase – mixture of buffer and acetonitrile (580:420), adjusted pH to 6.0 with 10 % sodium hydroxide. buffer - 4.08 g Potassium dihydrogen orthophosphate in 600 mL of water. The flow rate is 1.0 mL/min and the elutant is monitored at 230 nm with UV detector. The retention time of levocetirizine hydrochloride is 5.5. Precision shows that % relative standard deviation is about 1.1%. The percentage recovery of the levocetirizine from the dosage formulation is 99.6%. The results obtained for robustness and ruggedness of levocetirizine hydrochloride are well within the acceptance criteria. The proposed method is found to be simple, rapid, accurate and precise. The proposed methods are validated as per ICH guidelines and successfully applied for the determination of Levocetirizine tablet.
Year
Volume
11
Pages
1-17
Physical description
Contributors
  • Department of Chemistry, Annamalai University, Annamalainagar - 608002, India
author
  • Department of Chemistry, Annamalai University, Annamalainagar - 608002, India
References
  • [1] Suresh B, Osborne J. L. Quick dissolving films- A novel approach to drug delivery. Available from: http://www.drugdeliverytechnology.com. [Last accessed on 2011 Jan 10].
  • [2] Rekha MR, Chandra PS. Trends Biomater Artif Organs. 20 (2007) 1-6.
  • [3] Diab T, Biliaderis CG, Gerasopoulos D, Sfakiotakis E. J Sci Food Agric. 81 (2001) 988-1000.
  • [4] Revathi V. Fast Dissolving drug delivery system. Pharma Times 39 (2007) 22-3.
  • [5] Felton L. A, O’Donnell P.B., McGinity J. W. Aqueous polymeric coatings for pharmaceutical dosage forms. New York, USA: Informa health; 2008. Mechanical properties of polymeric films prepared from aqueous dispersions; pp. 176-178.
  • [6] Web ref. Available from: http://en.wikipedia.org/wiki/Levocetirizine. [Lastaccessed on 2008 Sept 23].
  • [7] Tillement JP, Testa B, Brée F., Biochem. Pharmacol. 66 (2003) 1123-1126.
  • [8] Horak F, Zieglmayer PU, Zieglmayer R, Kavina A, Lemell P. Brazilian J. Clin. Pharmacol. 60 (2005) 24-31.
  • [9] Potter PC; Study Group. Allergy. 58 (2003) 893-899.
  • [10] Kapp A, Pichler W.J., Int J. Dermatol. 45 (2006) 469-474.
  • [11] Mashru RC, Sutariya VB, Sankalia MG, Parikh PP., Drug Dev. Ind. Pharm. 35 (2005) 25-34.
  • [12] Brindle LP, Krochta JM., J. Food Sci. 73 (2008) 446-454.
  • [13] Doaa A. E, Nevine S. A., AAPS Pharm. Sci. Tech. 11 (2010) 1018-1024
  • [14] Uddhav B, Kishore G, Nancy P, Sanjeevani A, Shalaka D., Int. J. Pharm. Sci. 2 (2010) 76-80.
  • [15] Mahesh A, Shastri N, Sadanadam M., Current Drug Deliv. 7 (2010) 21-27.
  • [16] Mishra R, Amin A. Indian J. Pharm. Educ. Res. 45 (2011) 71-77.
  • [17] Dinge A, Nagarsenker M., AAPS Pharm. Sci. Tech. 9 (2008) 349-356.
  • [18] The Formulary US, Rockyvilley USP. The United State pharmacopoeial Convention Inde. NF 32 2014; USP 37.
  • [19] ICH (International Conference on Harmonization) – Guidelines Q2A, Validation of Analytical Procedures: Definition and terminology (CPMP III/5626/94) March Geneva, Switzerland. Journal of AOAC International 1995.
  • [20] ICH (International Conference on Harmonization) – Guidelines Q2B, Validation of Analytical Procedures: Methodology (CPMP/ICH/281/95) November Geneva, Switzerland. Journal of AOAC International 1996.
  • [21] British pharmacopoeia: The Stationery Office, London, 1 (2007) 1036-1037.
  • [22] Prabhakara Prabhu et. al., Int. J. Pharm. Invest. 1 (2011) 240-246.
  • [23] Rathore A. S., Sathiyanarayanan L, Mahadik K. R., Pharm. Anal. Acta. 1 (2010) 106.
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-f7e25244-3e27-421c-a941-392b3532960a
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.